Improving molecular testing and personalized medicine in non-small-cell lung cancer in Ontario

BACKGROUND: Although molecular testing has become standard in managing advanced nonsquamous non-small-cell lung cancer (nsclc), most patients undergo minimally invasive procedures, and the diagnostic tumour specimens available for testing are usually limited. A knowledge translation initiative to ed...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Curr Oncol
Autores principales: Lim, C., Sekhon, H.S., Cutz, J.C., Hwang, D.M., Kamel-Reid, S., Carter, R.F., Santos, G. da Cunha, Waddell, T., Binnie, M., Patel, M., Paul, N., Chung, T., Brade, A., El-Maraghi, R., Sit, C., Tsao, M.S., Leighl, N.B.
Formato: Artigo
Lenguaje:Inglês
Publicado: Multimed Inc. 2017
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5407861/
https://ncbi.nlm.nih.gov/pubmed/28490924
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.24.3495
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares